Article History
Received: 25 November 2024
Revised: 14 January 2025
Accepted: 15 January 2025
First Online: 14 February 2025
Competing interests
: J.G.B and L.G. have a patent application for the use of mitochondrial transfer technology in cancer immunotherapies. C.R.F.S. declares no competing interests.